Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.
Beffinger M, Tallón de Lara P, Tugues S, Vermeer M, Montagnolo Y, Ohs I, Cecconi V, Lucchiari G, Gagliardi A, Misljencevic N, Sutton J, Spörri R, Becher B, Gupta A, van den Broek M. Beffinger M, et al. Among authors: gagliardi a. JCI Insight. 2018 May 17;3(10):e97792. doi: 10.1172/jci.insight.97792. eCollection 2018 May 17. JCI Insight. 2018. PMID: 29769439 Free PMC article.
KatG as Counterselection Marker for Nontuberculous Mycobacteria.
Gagliardi A, Selchow P, Luthra S, Schäfle D, Schulthess B, Sander P. Gagliardi A, et al. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02508-19. doi: 10.1128/AAC.02508-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32317266 Free PMC article. No abstract available.
[Autistic burnout: concrete elements to understand it].
Violland P, Gagliardi A. Violland P, et al. Among authors: gagliardi a. Rev Med Suisse. 2025 Jun 11;21(922):1248-1251. doi: 10.53738/REVMED.2025.21.922.46414. Rev Med Suisse. 2025. PMID: 40509724 Review. French.
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.
Morabito F, Martino EA, Galli M, Offidani M, Zambello R, Bringhen S, Giuliani N, Califano C, Brunori M, Gagliardi A, Sgherza N, Quinto AM, Barilà G, Belotti A, Cerchione C, Casaluci GM, Fontana R, Bongarzoni V, Tarantini G, Derudas D, Patriarca F, Gozzetti A, Sementa A, Antonioli E, Rago A, Lotti F, De Magistris C, Petrucci MT, Pettine L, Bolli N, Conticello C, Zamagni E, Palmieri S, Musso M, Mele A, Della Pepa R, Vigna E, Bruzzese A, Fazio F, Mina R, Paris L, Vincelli ID, Farina G, Cangialosi C, Mancuso K, Falcone AP, Mele G, Sica A, Morè S, Reddiconto G, Tripepi G, D'Arrigo G, Barbieri E, Quaresima M, Cartia CS, Pezzatti S, Marcatti M, Farina F, Cafro A, Palumbo M, Masoni V, Ferretti VV, Di Raimondo F, Musto P, Neri A, Mangiacavalli S, Gentile M. Morabito F, et al. Among authors: gagliardi a. Eur J Haematol. 2025 Jul;115(1):16-28. doi: 10.1111/ejh.14413. Epub 2025 Mar 19. Eur J Haematol. 2025. PMID: 40103518 Free PMC article.
511 results